{"id":"W2208304134","doi":"10.1182/blood.v122.21.5378.5378","title":"Induction Therapy With Cyclophosphamide, Bortezomib, and Dexamethasone (CyBorD) For Primary Plasma Cell Leukemia (pPCL)","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Plasma cell leukemia; Bortezomib; Internal medicine; Cyclophosphamide; Gastroenterology; Dexamethasone; Median follow-up; Plasma cell dyscrasia; Melphalan; Multiple myeloma; Surgery; Chemotherapy; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002928573,0.0002471402,0.0003865941,0.0001134717,0.0001455662,0.00005714157,0.0001164568,0.0001947095,0.00008509364],"category_scores_gemma":[0.00008092284,0.0001828375,0.00006338241,0.0002372659,0.0001749215,0.0001980283,0.0000525915,0.000356386,0.00004111099],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002392696,"about_ca_system_score_gemma":0.003876762,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001280958,"about_ca_topic_score_gemma":0.00002281517,"domain_scores_codex":[0.9983538,0.00005117964,0.0002641155,0.0004274561,0.000399714,0.0005037357],"domain_scores_gemma":[0.9986815,0.0002941359,0.00009090485,0.0004551989,0.0002095924,0.000268631],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.007358112,0.006116208,0.02321942,0.003479563,0.001834041,0.0003199422,0.003401376,0.00004653454,0.4562377,0.0001705332,0.01098396,0.4868326],"study_design_scores_gemma":[0.287046,0.006465031,0.09894475,0.0003499087,0.0005407701,0.001849485,0.0008690362,0.002191824,0.5871111,0.0004702643,0.01320423,0.0009575219],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.993363,0.001276826,0.0001337852,0.0001760382,0.00006662073,0.002028184,0.000008189348,0.0001005032,0.002846905],"genre_scores_gemma":[0.9867563,0.0006936821,0.00915973,0.0003861293,0.0002722496,0.0005276251,0.00005050538,0.00008682242,0.002066959],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.485875,"threshold_uncertainty_score":0.7455898,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0133084105670059,"score_gpt":0.241517969213551,"score_spread":0.2282095586465451,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}